Syros Pharmaceuticals (LTS:0LC7) Marketable Securities : $0.00 Mil (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Syros Pharmaceuticals Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Syros Pharmaceuticals's Marketable Securities for the quarter that ended in Sep. 2024 was $0.00 Mil.

Syros Pharmaceuticals's annual Marketable Securities declined from Dec. 2021 ($38.07 Mil) to Dec. 2022 ($34.84 Mil) and declined from Dec. 2022 ($34.84 Mil) to Dec. 2023 ($0.00 Mil).

Syros Pharmaceuticals Marketable Securities Historical Data

The historical data trend for Syros Pharmaceuticals's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syros Pharmaceuticals Marketable Securities Chart

Syros Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

49.98

38.07

34.84

Syros Pharmaceuticals Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Marketable Securities	Get a 7-Day Free Trial															-	-	24.78	-	-

Syros Pharmaceuticals Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Syros Pharmaceuticals (LTS:0LC7) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Syros Pharmaceuticals Marketable Securities Related Terms

Thank you for viewing the detailed overview of Syros Pharmaceuticals's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Syros Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Syros Pharmaceuticals Inc (LTS:0LC7) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

SYRS:USA

Address

35 CambridgePark Drive, 4th Floor, Cambridge, MA, USA, 02140

Website

https://www.syros.com

Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.

Syros Pharmaceuticals Headlines

No Headlines